Research Overview of Bromocriptine Compounds
Parlodel Meda Pharma is a pharmaceutical-grade bromocriptine preparation manufactured by Meda Pharma for research applications. Bromocriptine is a semisynthetic ergot alkaloid that functions as a dopamine receptor agonist, making it valuable for dopamine pathway research studies. This compound demonstrates selective affinity for D2 dopamine receptors and exhibits additional interactions with D1 receptors and α-adrenergic receptors in laboratory models. Researchers at Stroid UK Shop can examine this well-characterised pharmaceutical reference standard in various experimental protocols investigating dopamine signalling pathways and receptor pharmacology.
Laboratory Research Applications
Scientists investigate bromocriptine preparations like Parlodel Meda Pharma across multiple research domains examining dopaminergic function. Cell culture studies analyse its effects on prolactin secretion pathways, growth hormone regulation, and neurotransmitter receptor binding kinetics. Pharmacokinetic researchers examine its oral bioavailability characteristics and metabolic pathways in experimental models. Neurochemistry laboratories study its interactions with central nervous system dopamine circuits, while endocrinology research focuses on its effects on pituitary hormone regulation. Researchers also evaluate its potential applications in models studying movement disorders, examining how dopamine agonist activity influences motor control pathways. This pharmaceutical preparation provides consistent dosing for comparative studies alongside other bromocriptine research compounds, enabling researchers to correlate findings with established clinical pharmacology data from this approved medication.
Product Specifications
| Parameter | Specification |
|---|---|
| Active Compound | Bromocriptine |
| Manufacturer | Meda Pharma |
| Form | Oral tablets |
| Chemical Formula | C₃₂H₄₀BrN₅O₅ |
| Molecular Weight | 654.60 g/mol |
| CAS Number | 25614-03-3 |
| Storage Requirements | Room temperature, dry environment |
Researchers studying dopamine receptor pharmacology often compare bromocriptine effects with selective androgen receptor modulators available through our SARMS collection and investigate potential interactions with peptide compounds that influence growth hormone pathways, creating comprehensive experimental protocols examining multiple receptor systems simultaneously.
Research Compliance Statement
Parlodel Meda Pharma bromocriptine tablets are supplied exclusively for in-vitro research purposes by qualified laboratory personnel. This pharmaceutical reference material is not approved for human consumption, therapeutic use, or any application outside controlled laboratory environments. Researchers must ensure compliance with institutional guidelines, local regulations, and appropriate safety protocols when handling this dopamine agonist compound. All studies should follow established pharmacological research standards and maintain proper documentation of experimental procedures and outcomes.
